Search

Displaying results 7541 - 7550 of 10000 in total
  1. Drug

    Vixotrigine

    go.drugbank.com/drugs/DB11706
    Investigational

    Vixotrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.

  2. Drug

    Pancreatic Polypeptide

    go.drugbank.com/drugs/DB12822
    Investigational

    Pancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.

  3. Drug

    IOWH-032

    go.drugbank.com/drugs/DB12959
    Investigational

    Iowh032 has been investigated for the treatment of Cholera, Diarrhea, and Secretory Diarrhea.

  4. Drug

    Avagacestat

    go.drugbank.com/drugs/DB11893
    Investigational

    Avagacestat has been investigated for the basic science and treatment of Alzheimer Disease.

  5. Drug

    Tanezumab

    go.drugbank.com/drugs/DB12335
    Investigational

    Tanezumab has been investigated for the treatment of Osteoarthritis, Knee and Neuralgia, Postherpetic.

  6. Drug

    E-7820

    go.drugbank.com/drugs/DB12505
    Investigational

    E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer.

  7. Drug

    Apaziquone

    go.drugbank.com/drugs/DB12593
    Investigational

    Apaziquone has been investigated for the treatment of Bladder Cancer and Bladder Neoplasms.

  8. Drug

    AD 337

    go.drugbank.com/drugs/DB05725
    Investigational

    The drug was created by Sosei pharmaceuticals to treat Fibromyalgia in female patients. … AD 337 was under investigation in clinical trial NCT00377039 (A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia).

  9. Drug

    Firmonertinib

    go.drugbank.com/drugs/DB16087
    Investigational

    Alflutinib is under investigation in clinical trial NCT03452592 (Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients With T790M).

  10. Drug

    Autologous Hematopoietic Peripheral Blood Stem Cells

    go.drugbank.com/drugs/DB17067
    Investigational

    Autologous hematopoietic peripheral blood stem cells were tested in a clinical trial (NCT00424489) by Northwestern University for the treatment of refractory myasthenia gravis.